Abstract:Drug discovery for complex liver diseases faces alarming attrition rates. The lack of non-clinical models that recapitulate key aspects of liver (patho)-physiology is likely contributing to the inefficiency of developing effective treatments. Of particular notice is the common omission of an organized microvascular component despite its importance in maintaining liver function and its involvement in the development of several pathologies. Increasing the complexity of in vitro models is usually associated with a lack of scalability and robustness which hinders their implementation in drug development pipelines. Here, we describe a comprehensive liver microphysiological system model comprising stellates, liver-derived endothelial cells and hepatocytes conceived within a scalable and automated platform. We show that endothelial cells self-organize in a microvascular network when co-cultured with stellates in a hydrogel. In a tri-culture, hepatocytes polarize accordingly, with a basolateral side facing blood vessels and an apical side facing bile-canaliculi-like structures. Stellates interact and surround the hollow microvessels. Steatosis was induced by exogenous administration of fatty acids which could be prevented by co-administration of firsocostat. Administration of TGF-β resulted in an activated stellate cells phenotype which could be prevented by the co-administration of SB-431542. The model was implemented on a microtiter plate format comprising 64 chips which enabled the development of a fully automated, multiplexed fibrosis assay with a robust Z' factor suitable for high-throughput applications.

In Vitro Models for the Study of Liver Biology and Diseases: Advances and Limitations

Insight to Biofabrication of Liver Microtissues for Disease Modeling: Challenges and Opportunities

Human Hepatobiliary Organoids: Recent Advances in Drug Toxicity Verification and Drug Screening

In vitro and in silico liver models: Current trends, challenges and opportunities

Liver Organoids: Established Tools for Disease Modeling and Drug Development

Development of novel tools for the in vitro investigation of drug-induced liver injury

Using Liver Organoids as Models to Study the Pathobiology of Rare Liver Diseases

Recent advances in the development of in vitro liver models for hepatotoxicity testing

A microvascularized in vitro liver model for disease modeling and drug discovery

Liver organoid as a 3D in vitro model for drug validation and toxicity assessment

Progress, Application and Challenges of Liver Organoids

A decade of liver organoids: Advances in disease modeling

Liver Organoids: Formation Strategies and Biomedical Applications

Advances and Applications in Liver Organoid Technology

In Vitro Culture of Isolated Primary Hepatocytes and Stem Cell-Derived Hepatocyte-Like Cells for Liver Regeneration

Human liver organoids: From generation to applications

In VitroandIn VivoHepatic Differentiation of Adult Somatic Stem Cells and Extraembryonic Stem Cells for Treating End Stage Liver Diseases

Constructing biomimetic liver models through biomaterials and vasculature engineering

Current Research Trends in the Application of In Vitro Three-Dimensional Models of Liver Cells